Vice President, Research at Glyphic Biotechnologies

Berkeley, California, United States

Apply Now

$188,000 – $296,000Compensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

PhD in biochemistry, chemistry, biophysics, or related field
Strong technical background in biochemistry
10+ years experience in people and project management, with increasing roles and responsibilities
Proven record of leading multidisciplinary teams
Comprehensive knowledge about nucleic acids biochemistry and bioconjugation
Proficiency in lab methods: PCR, electrophoresis, cytometry, NGS library preparation, mass spectrometry, and nanopore sequencing
Experience with transferring manual assays onto engineering prototypes or commercial robotic platforms
Experience in the development of a commercial product (highly desired)

Responsibilities

Collaborate with the CTO and executive leadership to define and execute a translational R&D strategy
Drive innovation in sample preparation, assay development, instrumentation, and data analysis
Solve critical challenges in integrating cutting-edge science with product development
Directly contribute to experimental work and troubleshoot technical challenges (approximately 25% of the time)
Analyze experimental data, identify trends, and iterate on protocols
Manage project timelines, milestones, and resource allocation
Foster professional development of scientists and engineers
Represent the company as a domain expert and thought leader

Skills

PCR

electrophoresis

cytometry

NGS library preparation

mass spectrometry

nanopore sequencing

bioconjugation

nucleic acids biochemistry

assay development

project management

Glyphic Biotechnologies

Develops next-generation protein sequencing platform

About Glyphic Biotechnologies

Glyphic Biotechnologies focuses on advancing the field of proteomics by developing a unique protein sequencing platform. This platform enables researchers to analyze proteins in detail, which helps them understand biological processes and diseases better. The technology works by providing advanced sequencing services that allow for in-depth study of protein structures and functions. Unlike other companies in the biotechnology sector, Glyphic Biotechnologies emphasizes a next-generation approach to protein sequencing, aiming to deliver insights that are not available through traditional methods. The company's goal is to enhance biological and medical research by providing tools that facilitate a deeper understanding of proteins and their roles in health and disease.

New York City, New YorkHeadquarters

2021Year Founded

$41.9MTotal Funding

EARLY_VCCompany Stage

Biotechnology, HealthcareIndustries

11-50Employees